Genetics testing services supplier Veritas is set to acquire fellow Boston-based start-up Curoserve for an undisclosed sum, according to anonymous insiders. Under the deal, Curoserve, which has developed an open-source platform called Arvados to store, manage and analyse genomic data, will continue to operate as a standalone business. The purchase is with a view to scaling up Veritas's abilities so it will be able to analyse thousands and even eventually millions of genomes a month. Veritas said in a statement that its acquisition was "consistent with our strategy to expand into new verticals while maintaining strong operational performance across all business units."
Genetics testing services supplier Veritas is set to acquire fellow Boston-based start-up Curoserve for an undisclosed sum, according to anonymous insiders. Under the deal, Curoserve, which has developed an open-source platform called Arvados to store, manage and analyse genomic data, will continue to operate as a standalone business. The purchase is with a view to scaling up Veritas's abilities so it will be able to analyse thousands and even eventually millions of genomes a month. Wellcome Trust Sanger Institute and IBM Watson are among the firms already using Arvados.